Experts are urging officials to rethink their decision on prostate cancer screening, after an MRI approach was shown to slash ...

Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

Government will consider committee’s guidance that says mass screening ‘likely to cause more harm than good’ ...

A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate ...

The Government’s plans for prostate cancer screening do not go far enough, experts have warned. James Murray, the new Health ...

Technologies combining MRI, robotics, and artificial intelligence are changing the way prostate cancer is diagnosed and ...

Australian men of all ages will soon be able to receive blood tests for prostate cancer as part of major changes to how the disease is diagnosed. Craig Watts, 61, was diagnosed with prostate cancer ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in ...

In this video, Mitchell Singstock, MD, discusses results of a retrospective study that evaluated genomic testing rates for ...